The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.

This clinical practice guideline, based on a systematic review, was developed to determine which chemotherapeutic agents (or combinations of agents) show the highest response rates, improved survival, quality of life, or symptom control in patients with advanced malignant pleural mesothelioma.